We noticed you’re blocking ads

Thanks for visiting CRSToday. Our advertisers are important supporters of this site, and content cannot be accessed if ad-blocking software is activated.

In order to avoid adverse performance issues with this site, please white list https://crstoday.com in your ad blocker then refresh this page.

Need help? Click here for instructions.

Cataract Surgery: Focus On Advanced Therapeutics | Apr 2010

Femtosecond Cataract Surgery With the Optimedica Platform

Femtosecond laser cataract surgery is compelling for its ability to provide a uniform outcome.

Optimedica Corporation (Santa Clara, CA) currently produces and markets advanced therapeutic lasers for the treatment of retinal diseases. The company has also recently developed a femtosecond laser platform that enables ophthalmologists to perform laser cataract surgery. In the evolving market for premium IOL surgery, this technology is designed to deliver a more accurate, metered, and consistent approach to cataract surgery to optimize the utility and performance of new-technology IOLs. Three companies are presently exploring the application of femtosecond laser technology for cataract surgery.

My colleagues and I are participating in an ongoing clinical trial at Centro Laser in Santo Domingo, Dominican Republic, using Optimedica Corporation’s femtosecond laser platform. I hope this technology will be available for my patients in the very near future.

Optimedica Corporation’s integrated optical coherence tomography (OCT) system maps the anterior segment. It measures the pupil size, the anterior chamber depth, the lens’ thickness, and the position of the anterior lens capsule immediately prior to laser surgery. The treatment software subsequently optimizes pattern parameters, such as the diameter and depth of lens fragmentation in real time.

A number of cutting patterns are available. The system today performs several corneal incisions, which can be used as primary cataract incisions, paracentesis, and relaxing incisions. With OCT-guided accurate placement, the platform delivers capsulotomies of any size and shape that the surgeon requires. These are features that one would expect on a platform like this and that expand its clinical utility.

Optimedica Corporation’s femtosecond laser system provides effective options for lens fragmentation, with patterns chosen based on the clinical examination, nuclear density, and OCT data. The treatment facilitates the removal of the nucleus and minimizes the required amount of phaco energy. In some cases, the laser treatment can eliminate phacoemulsification from the process.

The Optimedica platform allows the surgeon to optimize the primary cataract incision as well as the paracentesis so that they are reproducible with predictable results. Consistency of the capsulotomy is a key factor for ensuring optimal premium IOL implantation and for achieving targeted refractive endpoints. Exact placement of the lens is becoming increasingly important for accommodating lenses that require some optical-mechanical engagement of the ciliary body-capsular bag complex with a consistent (or at least reproducible and predictable) movement and noncircular capsulotomies. No surgeon believes he or she can create a capsulotomy freehand as precisely and reproducibly as the laser can.

In femtosecond cataract surgery, combining integrated OCT with flexible cutting patterns and laser precision contributes to a consistent outcome. This is why I find femtosecond cataract surgery using the platform from Optimedica Corporation appealing.

John A. Vukich, MD, is a partner at the Davis Duehr Dean Center for Refractive Surgery in Madison, Wisconsin. He is a consultant to and investigator for Optimedica Corporation. Dr. Vukich may be reached at (608) 282-2000; javukich@facstaff.wisc.edu.

For video of the procedure: http://eyetube.net/v.asp?dirufe

Advertisement - Issue Continues Below
Publication Ad Publication Ad
End of Advertisement - Issue Continues Below